Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
06/27/1991 | WO1991009045A1 Hepatocellular carcinoma oncogene |
06/27/1991 | WO1991008762A1 Production of biologically active platelet-derived growth factor from high expression host cell systems |
06/27/1991 | WO1991008761A1 Novel platelet-derived growth factor b chain analogs and method for homogeneous production thereof |
06/27/1991 | WO1990015159A3 Nucleic acid probes for the detection of chlamydia trachomatis |
06/27/1991 | DE3942580A1 Verfahren zur herstellung von hirudin A process for the preparation of hirudin |
06/27/1991 | CA2072017A1 Therapeutic uses of the hypervariable region of monoclonal antibody m195 and constructs thereof |
06/27/1991 | CA2070171A1 Proteins with oncostatin m activity and process for their preparation |
06/27/1991 | CA2032914A1 Use of bacterial lipoprotein amino terminus in fusion plasmids for in vivo expression of lipid modified polypeptides |
06/27/1991 | CA2006744A1 Nucleid acids and polypeptides encoded thereby |
06/26/1991 | EP0434670A1 Monoclonal antibodies |
06/26/1991 | EP0434616A1 Method and appliance for the genetic transformation of cells |
06/26/1991 | EP0434605A2 Novel process for the production of unfused protein in E. coli |
06/26/1991 | EP0434317A1 Immunoadsorbents |
06/26/1991 | EP0433945A2 Insecticides produced by transformation of B.t. Kurstaki with heterologeous genes |
06/26/1991 | EP0433900A1 Expression of the recombinant tumor necrosis factor binding protein I (TBP-I) |
06/26/1991 | EP0433827A2 Cytotoxic lymphocyte maturation factor and monoclonal antibodies directed thereto |
06/26/1991 | EP0433509A2 Polypeptides having thyrotropin receptor activity, nucleic acid sequences coding for such receptors and polypeptides, and applications of these polypeptides |
06/26/1991 | EP0433442A1 Hybrid molecules |
06/26/1991 | EP0433437A1 Method for determining oncogenic potential of a chemical compound |
06/26/1991 | EP0433431A1 New strain with filamentous fungi mutants, process for the production of recombinant proteins using said strain, and strains and proteins produced by said process |
06/26/1991 | EP0433372A1 Oral immunization by transgenic plants |
06/26/1991 | EP0433371A1 Fusion protein of paramyxovirus, method of production using recombinant baculovirus expression vector, vaccine comprising such protein and use thereof |
06/26/1991 | CN1052508A Polypeptides, dna sequences allowing their expression, method of preparation, utilization |
06/26/1991 | CN1052507A Structural method of spiramycin streptomycete with cloned propionyl-enzyme gene |
06/25/1991 | US5026839 Angiogenesis, mitotic and chemotaxic activity; stimulation of protease synthsis; equivalent to factors from human placenta |
06/25/1991 | US5026651 Methods and compositions for the production of human transferrin |
06/25/1991 | US5026645 Cultivation of plasmid-containing escherichia coli; radio-active detectors |
06/25/1991 | US5026639 Method to improve mRNA translation and use thereof for production of platelet factor-4 |
06/25/1991 | US5026636 Methods and compositions for production of mycoplasmal adhesins |
06/25/1991 | US5026635 Exposing genetically engineered cells to inhibitor, measuring decrease in protein expressed; screening viricides |
06/25/1991 | CA1285330C Analyte detection by means of energy transfer |
06/25/1991 | CA1285233C Method for the production of neutral protease |
06/25/1991 | CA1285222C Monoclonal antibodies useful in the identification of microorganisms causing periodontal disease |
06/23/1991 | WO1991009955A1 Endogenous gene expression modification with regulatory element |
06/23/1991 | WO1991009947A1 Polypeptides having serine protease inhibitor activity and dna coding therefor |
06/23/1991 | WO1991009946A1 Method of preparation of hirudin |
06/23/1991 | WO1991009945A1 Neutrophil chemoattractants |
06/23/1991 | WO1991009944A2 High temperature reverse transcriptases |
06/23/1991 | WO1991009871A1 Hybrid molecules having translocation region and cell-binding region |
06/23/1991 | CA2572802A1 Cytotoxic lymphocyte maturation factor and monoclonal antibodies directed thereto |
06/23/1991 | CA2072012A1 Neutrophil chemoattractants |
06/23/1991 | CA2071969A1 Hybrid molecules having translocation region and cell-binding region |
06/23/1991 | CA2070399A1 Polypeptides and dna coding therefor |
06/23/1991 | CA2066442A1 Method of preparation of hirudin |
06/23/1991 | CA2033042A1 Methods for diagnosis of tuberculosis |
06/22/1991 | WO1991009968A1 Cd3 specific recombinant antibody |
06/22/1991 | WO1991009965A1 An improved toxin for construction of immunotoxins |
06/22/1991 | WO1991009939A1 Transformed cell lines |
06/22/1991 | CA2071998A1 Transformed cell lines |
06/22/1991 | CA2071946A1 Toxin for construction of immunotoxins |
06/22/1991 | CA2032842A1 Bovine myogenic factor gene |
06/21/1991 | WO1991009132A1 Cloning vector for use in lactic acid bacteria and a method for constructing the same |
06/21/1991 | WO1991009127A1 BCRF1 PROTEINS AS INHIBITORS OF INTERFERON-$g(g) |
06/21/1991 | WO1991009073A1 Uncharged morpholino-based polymers having achiral intersubunit linkages |
06/21/1991 | WO1991009033A1 Uncharged morpholino-based polymers having phosphorous-containing chiral intersubunit linkages |
06/21/1991 | CA2018377A1 Sequential peptide and oligonucleotide syntheses using immunoaffinity techniques |
06/20/1991 | WO1991009126A1 Production of human basic fgf mutein |
06/20/1991 | CA2070989A1 Production of human basic fgf mutein |
06/20/1991 | CA2032675A1 Platelet-derived growth factor b chain analogs and method for homogeneous production thereof |
06/20/1991 | CA2032443A1 Process and apparatus for the genetic transformation of cells |
06/19/1991 | WO1991009129A1 Stable integration of dna in bacterial genomes |
06/19/1991 | EP0433225A1 Process for the production of biologically active protein (e.g. TGF) |
06/19/1991 | EP0433117A1 Novel polypeptides, the DNA sequences allowing their expression, method of preparation, and utilization |
06/19/1991 | EP0433088A1 Monoclonal antibodies reactive with a human atheroma associated antigen |
06/19/1991 | EP0432965A1 Malaria vaccine |
06/19/1991 | EP0432510A1 Process for the preparation of genetic vectors for the nerve growth factor expression in eukaryotic cells |
06/19/1991 | EP0432254A1 NUCLEIC ACID CODING FOR THE HUMAN TESTICULAR ANGIOTENSIN CONVERSION ENZYME (ECA) AND ITS APPLICATIONS, IN PARTICULAR FOR THE $i(IN VITRO) DETECTION OF SAID ENZYME IN THE ORGANISM |
06/19/1991 | EP0432216A1 Recombinant retroviruses with amphotropic and ecotropic host ranges |
06/19/1991 | EP0432196A1 Vaccine |
06/19/1991 | EP0309559A4 Transgenic animals |
06/19/1991 | EP0254735B1 Thermally stable and ph stable subtilisin analogs and method for production thereof |
06/19/1991 | EP0203967B1 Onco-fetal specific monoclonal antibodies, methods of preparation and use |
06/19/1991 | EP0201540B1 Envelope antigens of lymphadenopathy associated virus and their applications |
06/19/1991 | CN1052331A Novel antigens and methods therefor |
06/19/1991 | CA2070676A1 Stable integration of dna in bacterial genomes |
06/19/1991 | CA2032405A1 Organic compounds |
06/19/1991 | CA2032389A1 Reagents |
06/18/1991 | US5024948 Genetically6 engineered actinomyces which produce antitumor-antibacterial complexes by aerobic fermentation |
06/18/1991 | US5024947 Containing a basal medium, a lipid, a peptone and a protective agent |
06/18/1991 | US5024944 Tissue culturing with 1-naphthaleneacetic acid as auxin |
06/18/1991 | US5024943 Regulatory region cloning and analysis plasmid for bacillus |
06/18/1991 | US5024941 Genetic engineering |
06/18/1991 | US5024940 Nucleic acids encoding the delta chain of the T cell antigen receptor |
06/18/1991 | US5024939 Transient expression system for producing recombinant protein |
06/18/1991 | US5024938 Culturing |
06/18/1991 | US5024837 Bacillus thuringiensis with acquired toxin-encoding plasmid; genetic engineering |
06/18/1991 | CA1284959C Dna sequence useful for the production and secretion from yeast of peptides and proteins |
06/18/1991 | CA1284931C Process for detecting specific nucleotide variations and genetic polymorphisms present in nucleic acids |
06/16/1991 | CA2032359A1 Monoclonal antibodies reactive with a human atheroma associated antigen |
06/16/1991 | CA2031831A1 Production method for foreign protein |
06/15/1991 | WO1991009141A1 Magnetically responsive fluorescent polymer particles and application thereof |
06/15/1991 | CA2017389A1 Alteration of ability of soluble cd4 protein to bind class ii mhc antigens |
06/14/1991 | CA2071858A1 Hiv-1 env fragment fusion protein |
06/13/1991 | WO1991009112A1 Genetic control of ethylene biosynthesis in plants |
06/13/1991 | WO1991008482A1 Antibody variable domain conjugates |
06/13/1991 | WO1991008478A2 METHODS OF DETECTING COLLAGEN DEGRADATION $i(IN VIVO) |
06/13/1991 | WO1991008312A1 Detection of hpv transcripts |
06/13/1991 | WO1991008308A1 A new method for detecting a specific nucleic acid sequence in a sample of cells |
06/13/1991 | WO1991008299A2 Dna, constructs, cells and plants derived therefrom |
06/13/1991 | WO1991008298A2 Fusion proteins consisting of a ligand binding protein and a stable plasma protein |